𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correction to: “Exponential bounds on the number of designs with affine parameters”

✍ Scribed by David Clark; Dieter Jungnickel; Vladimir D. Tonchev

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
126 KB
Volume
19
Category
Article
ISSN
1063-8539

No coin nor oath required. For personal study only.

✦ Synopsis

This article replaces the incorrect version of the article first published in J Combin Designs 18 (2010), 450-461. The publisher apologizes for this error.

📜 SIMILAR VOLUMES

Exponential bounds on the number of desi
Exponential bounds on the number of designs with affine parameters
✍ David Clark; Dieter Jungnickel; Vladimir D. Tonchev 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract It is well‐known that the number of designs with the parameters of a classical design having as blocks the hyperplanes in __PG__(__n, q__) or __AG__(__n, q__), __n__≥3, grows exponentially. This result was extended recently [D. Jungnickel, V. D. Tonchev, Des Codes Cryptogr, published on

A study of the effects of mis-specificat
A study of the effects of mis-specification of the Weibull shape parameter on confidence bounds based on the Weibull-to-exponential transformation
✍ J. Bert Keats; Peeyush C. Nahar; Kristen M. Korbel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 3 views

Many authors of reliability texts and papers recommend or employ the Weibull-to-exponential transformation for ease of use in testing hypotheses and in constructing confidence intervals and bounds on the Weibull characteristic value. In making this transformation, it is assumed that the Weibull shap

On the calculation of the concentration
On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: Determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein
✍ Leonid M. Berezhkovskiy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

The measurement of the unbound drug fraction in plasma is routinely performed at drug concentrations much less than that of plasma proteins. Commonly, the protein has several binding sites of different affinities. The obtained value of the unbound drug fraction does not yield the affinity of each bi